Apr 28, 2020
ArcherDX and UCL Present New Minimal Residual Disease Surveillance Data from their Collaboration at 2020 AACR Virtual Annual Meeting
Apr 21, 2020
Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology
Feb 18, 2020
Volition Unveils Its Epigenetic Toolbox
Feb 14, 2020
The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2019-2025
Jan 14, 2020
Genomic Testing Cooperative (GTC) and C2i Genomics Announce Collaboration to Offer Liquid Biopsy Testing for Staging and Monitoring Solid Tumors Based on Pattern Recognition of Whole Genome DNA Signature
Jan 07, 2020
Predicine and Merck KGaA, Darmstadt, Germany to Present Data at AACR - Advances in Liquid Biopsy Conference 2020
Sep 26, 2019
Eurofins Viracor, Inc. Responds to Patent Infringement Lawsuit By CareDx
Jun 17, 2019
CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury
May 28, 2019
CELLSEARCH Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer
May 21, 2019
Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera(TM) Kidney Transplant Test
Apr 26, 2019
The Liquid Biopsy Market in Latin America, 2019 to 2025 - Products Based on Circulating Tumor Cells (CTCs) is Anticipated to Witness the Highest CAGR of 11.75% during 2018-2025
Mar 28, 2019
Medicare Issues Draft Local Coverage Determination for Natera's New Prospera(TM) Kidney Transplant Rejection Test
Mar 26, 2019
Natera to Partner with AMAL Therapeutics on Clinical Trial Using Signatera MRD Test to Assess Treatment Response to Colorectal Cancer Vaccine
Mar 19, 2019
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
Feb 28, 2019
Apostle Inc. Enters Partnership with Beckman Coulter Life Sciences
Feb 11, 2019
Study Validates Karius Test to Identify Life-Threatening Infections
Feb 01, 2019
Natera Announces Agreement with One Lambda to Co-Distribute Its Kidney Transplant Rejection Test
Jan 07, 2019
San Diego Blood Chip Maker BioFluidica Awarded Two NIH/NCI Grants for Isolation of Cell-Free DNA and Exosomes on Its Single Liquid Biopsy Platform
Jan 07, 2019
Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection
Dec 06, 2018
Natera Presents Breast Cancer Data at SABCS Showing Ability of Signatera (RUO) to Detect Molecular Residual Disease Up to Two Years Prior to Clinical Relapse and Predict Treatment Response